156 related articles for article (PubMed ID: 35421230)
1. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.
Gaydosik AM; Stonesifer CJ; Khaleel AE; Geskin LJ; Fuschiotti P
Clin Cancer Res; 2022 Jun; 28(12):2610-2622. PubMed ID: 35421230
[TBL] [Abstract][Full Text] [Related]
2. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
[TBL] [Abstract][Full Text] [Related]
3. Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors.
Quadri I; Reneau JC; Hanel W; Chung CG
Front Immunol; 2023; 14():1291259. PubMed ID: 38022633
[TBL] [Abstract][Full Text] [Related]
4. Changes to Registered and Pivotal Clinical Trials after the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome.
Gunter SJ; Kim EJ
J Invest Dermatol; 2024 Apr; 144(4):855-861.e1. PubMed ID: 37925066
[TBL] [Abstract][Full Text] [Related]
5. The biomarker landscape in mycosis fungoides and Sézary syndrome.
Dulmage B; Geskin L; Guitart J; Akilov OE
Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
[TBL] [Abstract][Full Text] [Related]
6. Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study.
Belfrage E; Ek S; Johansson Å; Brauner H; Sonesson A; Drott K
JMIR Res Protoc; 2024 Apr; 13():e55723. PubMed ID: 38436589
[TBL] [Abstract][Full Text] [Related]
7. Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon.
Jiang TT; Kruglov O; Akilov OE
Blood Adv; 2024 May; 8(10):2384-2397. PubMed ID: 38489234
[TBL] [Abstract][Full Text] [Related]
8. Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.
Abrams JT; Vonderheid EC; Kolbe S; Appelt DM; Arking EJ; Balin BJ
Clin Diagn Lab Immunol; 1999 Nov; 6(6):895-905. PubMed ID: 10548583
[TBL] [Abstract][Full Text] [Related]
9. CD39 is expressed by a wide range of cutaneous T-cell lymphomas.
Battesti G; Thonnart N; Bozonnat A; Ram-Wolff C; de Masson A; Bensussan A; Bagot M; Marie-Cardine A; Battistella M
Skin Health Dis; 2024 Apr; 4(2):e334. PubMed ID: 38577051
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes.
Almaani N; Farhan F; Bani Hamad S; Abuhawileh EA; Koubaitary L; Ahram M; Aladily TN
J Int Med Res; 2024 Mar; 52(3):3000605241239034. PubMed ID: 38546260
[TBL] [Abstract][Full Text] [Related]
11. Nasal Dysbiosis in Cutaneous T-Cell Lymphoma Is Characterized by Shifts in Relative Abundances of Non-
Hooper MJ; LeWitt TM; Veon FL; Pang Y; Chlipala GE; Feferman L; Green SJ; Sweeney D; Bagnowski KT; Burns MB; Seed PC; Guitart J; Zhou XA
JID Innov; 2022 Sep; 2(5):100132. PubMed ID: 36161104
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing reveals the underlying mechanism of folliculotropism in folliculotropic mycosis fungoides.
Shi HZ; Tian CC; Kong YQ; Sun JF; Chen H
Exp Dermatol; 2024 Jan; 33(1):e14992. PubMed ID: 38284188
[No Abstract] [Full Text] [Related]
13. Gelling Your Dermatology Nursing Practice: A Practical Guide for Managing the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
McCann SA; Chase AB; Tawa MC
J Dermatol Nurses Assoc; 2016 May; 8(3):180-192. PubMed ID: 28529678
[TBL] [Abstract][Full Text] [Related]
14. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.
Wang L; Ni X; Covington KR; Yang BY; Shiu J; Zhang X; Xi L; Meng Q; Langridge T; Drummond J; Donehower LA; Doddapaneni H; Muzny DM; Gibbs RA; Wheeler DA; Duvic M
Nat Genet; 2015 Dec; 47(12):1426-34. PubMed ID: 26551670
[TBL] [Abstract][Full Text] [Related]
15. Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation.
Wobser M; Roth S; Appenzeller S; Houben R; Schrama D; Goebeler M; Geissinger E; Rosenwald A; Maurus K
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771672
[TBL] [Abstract][Full Text] [Related]
16. The Interferon story continues: EORTC CLTG Study Explores Pegylated Interferon Alpha-2α's Role in Treating Mycosis Fungoides/Sézary Syndrome.
Stadler R
Br J Dermatol; 2024 May; ():. PubMed ID: 38703059
[No Abstract] [Full Text] [Related]
17. Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet.
Dar N; Roberts N; Gru A; Obiorah I; Zheng J; Shields LK; Cropley T; Marchi E
JAAD Case Rep; 2024 Jun; 48():18-22. PubMed ID: 38741658
[No Abstract] [Full Text] [Related]
18. Tumor Stage Mycosis Fungoides with Lymph Node Involvement.
Mills K; Sigler E; Snell M; Regehr J; Moore D; Ablah E; Gilbert L
Kans J Med; 2024; 17():39-40. PubMed ID: 38694178
[No Abstract] [Full Text] [Related]
19. Staphylococcus aureus and Sézary syndrome.
Merlio JP
Blood; 2024 Apr; 143(15):1436-1438. PubMed ID: 38602696
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
